Archives

  • 2018-07
  • 2018-10
  • 2018-11
  • 2019-04
  • 2019-05
  • 2019-06
  • 2019-07
  • 2019-08
  • 2019-09
  • 2019-10
  • 2019-11
  • 2019-12
  • 2020-01
  • 2020-02
  • 2020-03
  • 2020-04
  • 2020-05
  • 2020-06
  • 2020-07
  • 2020-08
  • 2020-09
  • 2020-10
  • 2020-11
  • 2020-12
  • 2021-01
  • 2021-02
  • 2021-03
  • 2021-04
  • 2021-05
  • 2021-06
  • 2021-07
  • 2021-08
  • 2021-09
  • 2021-10
  • 2021-11
  • 2021-12
  • 2022-01
  • 2022-02
  • 2022-03
  • 2022-04
  • 2022-05
  • 2022-06
  • 2022-07
  • 2022-08
  • 2022-09
  • 2022-10
  • 2022-11
  • 2022-12
  • 2023-01
  • 2023-02
  • 2023-03
  • 2023-04
  • 2023-05
  • 2023-06
  • 2023-08
  • 2023-09
  • 2023-10
  • 2023-11
  • 2023-12
  • 2024-01
  • 2024-02
  • 2024-03
  • 2024-04
  • br Health benefits of mushroom DF Compared to

    2018-11-12


    Health benefits of mushroom DF Compared to Asian countries such as China, Korea and Japan, the application of medicinal mushrooms in the Western countries is more recent [35–37]. Medicinal mushrooms are characterized by having cell wall polysaccharides and proteins as well as fungal secondary metabolites including lignins, triperpenes and phenolics that have a broad spectrum of pharmacological activities [35,36]. On the other hand, edible mushrooms are rich in DF with NDCs including β-glucans, polysaccharide–protein complexes (PSPC) and chitin that also has a wide range of health benefits to humans. The beneficial health effects of mushroom DF that have been studied include the immune-enhancing and antitumor activity as well as blood glucose and lipid attenuation [38–43]. Some commercial β-glucans isolated from the fruiting bodies of Lentinus edodes (lentinan) and Grifola frondosa (D-fraction) as well as PSPC from Trametes versicolor were shown to stimulate the non-specific immune system in animals to inhibit cancer cell proliferation [38]. They are regarded as immunomodulators and have been used as adjuvant in cancer therapy with certain success [44–46]. It has recently been shown that a PSPC isolated from an edible mushroom Pleurotus pulmonarius can suppress in vitro and in vivo liver cancer development and progression through inhibition of VEGF-induced PI3K/AKT signaling pathway [47]. Apart from β-glucans, heteropolysaccharides such as glucuronoxylomannan isolated from the fruiting bodies of Tremella fuciformis and Tremella mesenterica exhibited immunomodulatory and hypoglycemic effects in animal studies [42,48].
    Biopharmacological effect of sclerotial DF As mentioned earlier, mushroom sclerotium is a rich source of DF source and contains extremely high level of β-glucans (>80% DM) that can have a number of biopharmacological effects that are beneficial to humans [49]. It has been reported that both the innate and adaptive immunity of the host could be stimulated by sclerotial β-glucans to trigger strong immunomodulatory mediated by cytokine production and signaling cascade as well as direct inhibition of cancer cells via keap1-nrf2 pathway arrest and cytotoxicity [50–54]. Native sclerotial β-glucans isolated from the P. tuber-regium could induce apoptosis of acute promyelocytic leukemic cells (HL-60) [52], while their carboxymethylated counterparts could induce both in vitro cell cycle arrest and apoptosis of human breast cancer cells (MCF-7) mediated by the down-regulation of cyclin D1 and cyclin E expressions at the G1 phase as well as and the up-regulation of the expression of the Bax/Bcl-2 ratio, respectively [53]. Chemical modifications of native sclerotial β-glucans from P. tuber-regium by carboxymethylaion and sulfation could enhance the immunomodulatory and anti-tumor activities of these new derivatives when they were administered intraperitoneally on BALB/c mice bearing Sarcoma 180 solid tumor [55,56]. The mechanisms of the in vivo immunomodulatory and anti-tumor activities of sclerotial β-glucans are not well understood but it is very likely that some kind of surface receptor interactions between the immune cells and β-glucans might have been involved. Dectin-1 has been identified as a β-glucan receptor found on the surface of a number of innate immune cells including monocytes, macrophages, NK cells and dendritic cells in human and mice recently [57,58]. Dectin-1 receptor was able to recognize β-glucans keap1-nrf2 pathway derived from yeast to trigger immunomodulation in both humans and mice [59,60]. The new approach of identifying similar or novel β-glucans receptor(s) that are specific to sclerotial β-glucans on the surface of innate human primary cells would be a promising new one and would provide new insights in explaining the immunomodulatory and anti-tumor effects of sclerotial β-glucans [50]. There are other biopharmacological activities of sclerotial polysaccharides isolated from P. tuber-regium that have been reported. These include hepatic protection against acute liver injury induced by carbon tetrachloride in mice and lowering of fasting blood glucose level in alloxan-induced diabetic mice [61]. Chemically modified sclerotial β-glucans derived from P. tuber-regium also have interesting biological activities that could not be found in their native counterparts. For instance, sulfated sclerotial β-glucans isolated from P. tuber-regium possessed anti-viral activity against human simplex virus including HSV-1 and HSV-2 which was probably due to their increased aqueous solubility and more opened chain conformation compared to the native ones [62,63]. Both sulfated and carboxymethylated sclerotial β-glucans obtained from P. tuber-regium could scavenge superoxide and hydroxyl radicals and protect the oxidative damage of liver mitochondria and DNA [64–66].